A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
We describe here a technique that combines transposon mutagenesis with high-throughput sequencing to identify and quantify transposon leptospiral mutants in tissues after a challenge of hamsters. This protocol can be used to screen mutants for survival and dissemination in animals and can also be applied to in vitro studies.
In this manuscript, we describe a transposon sequencing (Tn-Seq) technique to identify and quantify Leptospira interrogans mutants altered in fitness during infection of Golden Syrian hamsters. Tn-Seq combines random transposon mutagenesis with the power of high-throughput sequencing technology. Animals are challenged with a pool of transposon mutants (input pool), followed by harvesting of blood and tissues a few days later to identify and quantify the number of mutants in each organ (output pools). The output pools are compared to the input pool to evaluate the in vivo fitness of each mutant. This approach enables screening of a large pool of mutants in a limited number of animals. With minor modifications, this protocol can be performed with any animal model of leptospirosis, reservoir host models such as rats and acute infection models such as hamsters, as well as in vitro studies. Tn-Seq provides a powerful tool to screen for mutants with in vivo and in vitro fitness defects.
Identification of virulence genes for some bacteria, such as Leptospira spp., is difficult because of the limited number of genetic tools available. One commonly used approach is the creation of a collection of mutants by random transposon mutagenesis followed by the identification of the insertion site in each mutant and virulence testing of individual transposon mutants in an animal model. This approach is time-consuming, expensive, and requires a large number of animals.
When random mutagenesis was first developed for the pathogen Leptospira interrogans, genes involved in virulence were identified by testing individual mutants in an animal model1. Mutants were selected based on criteria such as their potential roles in signaling or motility or their predicted outer membrane or surface location. As the majority of leptospiral genes encode hypothetical proteins of unknown function2, selecting mutants based on these criteria limits the ability to discover novel leptospiral virulence genes.
More recently, pools of L. interrogans transposon mutants were screened for infectivity in the hamster and mouse models3. Each animal was challenged with a pool of up to 10 mutants. Infectivity of a mutant was scored as positive if it was detected by PCR of cultures obtained from blood and kidney. PCR testing was laborious because it required an individual PCR reaction for each mutant in the pool. Because the frequency of each mutant in the cultures was not quantified, the approach was biased towards identification of highly attenuated mutants.
We describe a transposon sequencing (Tn-Seq) technique, as a strategy to more efficiently screen for virulence genes. Tn-seq consists of the creation of a library of mutants by transposon mutagenesis followed by massive parallel sequencing4,5,6. Briefly, transposon mutants are pooled, inoculated into animals, and later recovered from different organs (output pools). The DNA from the output pools is extracted and digested with restriction enzymes or sheared by sonication. Two rounds of PCR targeting the junctions of the transposon insertion sites are performed. This step enables the addition of the adaptors necessary for the sequencing. The resulting PCR products are analyzed by high-throughput sequencing to identify the transposon insertion site of each mutant of the pool along with their relative abundance, which is compared to the initial composition of the pool of mutant.
The primary advantage of this approach is the ability to simultaneously screen a large number of mutants with a small number of animals. Tn-Seq does not require the prior knowledge of the transposon insertion sites which increases the chances of discovering new Leptospira-specific genes involved in virulence with less time and greater efficiency. Because leptospiral burden in tissues is relatively high in rodent models susceptible to lethal infection (typically 104 to 108 bacteria/g of tissue)7,8,9 as well as in reservoir hosts10,11, tissues can be directly analyzed without the need to culture, reducing biases due to in vitro growth.
In Tn-Seq studies with most bacterial pathogens described to date, the high frequency of insertional mutagenesis allowed infection with large pools containing mutants collectively having multiple closely-spaced transposon insertions within every gene4,12,13,14. Tn-Seq has also been developed for a bacterium for which the mutagenesis frequency is much lower6. With Leptospira, a library of transposon mutants can be generated by introducing the transposon on a mobilizable plasmid by conjugation as described by Slamti et al15. However, the frequency of transposon mutagenesis of L. interrogans is low. When the Himar1 transposon was introduced on a conjugative plasmid, the transconjugant frequency was reported to be only 8.5 x 10-8 per recipient cell with the Lai strain of L. interrogans16 and is likely to be similarly poor with most other strains of L. interrogans. The protocol described here is in part based on that developed for Borrelia burgdorferi, in which the frequency of transposon insertional mutagenesis is also low6.
For our pilot experiment with the protocol17, we conducted transposon mutagenesis with L. interrogans serovar Manilae strain L495 because of the success of other groups in isolating transposon insertion mutants in the strain along with its low LD50 (lethal dose) for virulence1. We screened 42 mutants by Tn-Seq and identified several mutant candidates defective in virulence, including two with insertions in a candidate adenylate cyclase gene. Individual testing of the two mutants in hamsters confirmed that they were deficient in virulence17.
CAUTION: Pathogenic strains of Leptospira spp. must be handled under Biosafety Level 2 (BSL-2) containment procedures. Appropriate personal protective equipment (PPE) must be worn. A Class II biosafety cabinet must be used for all manipulations of pathogenic Leptospira spp.
1. Creation of the Transposon Mutant Library15
2. Animal Experiment (Figure 3)
3. Construction of Genomic Libraries for High-throughput Sequencing (Figure 4)
4. High-throughput Sequencing and Data Analysis
Creation of a library of transposon mutants in L. interrogans by conjugation requires a filtration unit, as shown in Figure 1. We recovered 100-200 transconjugants from each mating.
The transposon insertion site is identified in each mutant by sequencing the PCR product generated by semi-random PCR that targets the end of the transposon and adjacent host sequences15 ...
Although results from our pilot experiment for hamster challenged intraperitoneally with 42 L. interrogans mutants are presented17, we expect that larger pools of mutants can be screened by Tn-Seq. Because the frequency of transconjugants is low (100-200 transconjugants/mating), several matings are necessary to generate a sufficient number of mutants for large Tn-Seq experiments. Maintaining a large number of mutants in liquid cultures presents logistical challenges that must be addressed...
The authors have nothing to disclose.
This work was supported by a Veterans Affairs Merit Award (to D.A.H.) and a National Institute of Health grant R01 AI 034431 (to D.A.H.).
Name | Company | Catalog Number | Comments |
Kanamycin sulfate from Streptomyces kanamyceticus | Sigma-Aldrich | K4000 | |
2,6-diaminopimelic acid | Sigma-Aldrich | D1377 | |
Spectinomycin dihydrochloride pentahydrate | Sigma-Aldrich | S4014 | |
Axio Lab A1 microscope with a darkfieldcondenser | Zeiss | 490950-001-000 | |
DNeasy blood and tissue kit | Qiagen | 69504/69506 | |
MinElute PCR Purification | Qiagen | 28004/28006 | |
QIAquick PCR purification kit | Qiagen | 28104/28106 | |
Model 505 Sonic Dismembrator | Fisher Scientific | FB-505 | |
2.5" Cup horn | Fisher Scientific | FB-4625 | |
Bead Ruptor 24 | Omni International | 19-010 | Step 3.1.2.4 |
Terminal deoxynucleotidyl transferase | Promega | M828C | |
Master mix Phusion | Thermo Scientific | F531 | Preparation of genomic libraries, step 3.4. |
DreamTaq Master Mix | Thermo Scientific | K9011/K9012 | Identification of the transposon insertion site, step 1.2. |
dCTP | Thermo Scientific | R0151 | |
ddCTP | Affymetrix/ USBProducts | 77112 | |
T100 Thermal cycler | BioRad | 1861096 | |
Qubit 2.0 fluorometer | Invitrogen | Q32866 | step 3.6. |
Qubit dsDNA HS assay kit | Invitrogen | Q32851/Q32854 | step 3.6. |
Qubit assay tubes | life technologies | Q32856 | step 3.6. |
PBS pH 7.2 (1X) | Gibco | 20012-027 20012-050 | |
Disposable scalpel No10 | Feather | 2975#10 | |
Plastic K2 EDTA 2 ml tubes | BD vacutainer | 367841 | |
syringe U-100 with 26G x ½” needle | BD vacutainer | 329652 | IP challenge, step 2.2.1. |
3 mL Luer-Lok tip syringe | BD vacutainer | 309657 | Cardiac puncture, step 2.4.2. |
25G X 5/8” needle | BD vacutainer | 305901 | Cardiac puncture, step 2.4.2. |
25 mm fritted glass base with stopper | EMD Millipore | XX1002502 | Filtration unit system, step 1.1.7. |
25 mm aluminum spring clamp | EMD Millipore | XX1002503 | Filtration unit system, step 1.1.7. |
15 ml borosilcate glass funnel | EMD Millipore | XX1002514 | Filtration unit system, step 1.1.7. |
125 ml side-arm Erlenmeyer flask | EMD Millipore | XX1002505 | Filtration unit system, step 1.1.7. |
Acetate-cellulose filter VVPP (pore size 0.1 mm; diameter 25 mm) | EMD Millipore | VVLP02500 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved